Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin K antagonist versus NOACs in well-controlled non-valvular atrial fibrillation
2013-004805-14Phase 4Completed
- Sponsor
- University Medical Center Groningen
- Start
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of acenocoumarol, dabigatran, rivaroxaban and apixaban in nonvalvular atrial fibrillation (NVAF) (2 arms), sponsored by University Medical Center Groningen. Started Apr 2014; status: completed.
02
Drugs
acenocoumaroldabigatranrivaroxabanapixaban
03
Conditions
nonvalvular atrial fibrillation (NVAF)
Beyond the preview
Go deeper on 2013-004805-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-004805-14.